Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-640-0 | CAS number: 136920-07-5 KEROFLUX ES 3241
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- A mixture of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
- EC Number:
- 406-640-0
- EC Name:
- A mixture of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
- Cas Number:
- 136920-07-5
- Molecular formula:
- C58H114N4O6 - C154H308N6O4
- IUPAC Name:
- Reaction mass of 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C12-C18)alkylacetamide and {[2-(Carboxymethyl-di(C12-C18)alkylcarbamoylmethyl-amino)-ethyl]-di(C12-C18)alkylcarbamoylmethyl-amino}-acetic acid
- Reference substance name:
- Keroflux Es 3241
- IUPAC Name:
- Keroflux Es 3241
- Details on test material:
- - Lot No.: T 75492/ST 1414/90, Part 1
- Physical state: solid, light beige; after heating at about 50°C: liquid, yellow
- Storage condition of test material: Refrigerator
- Date of manufacturing: 1990-10-10
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Hagemann GmbH & Co. KG, Extertal, D (strain: Pirbright White, Dunkin Hartley HOE DHPK [SPF-LAC) BÖ)
- Weight at study initiation: 283 - 354 g
- Housing: 5 per cage (Makrolon, type IV)
- Diet: Kliba 341 4 mm, Klingentalmuehle AG, Kaiseraugst, CH; ad libitum
- Water: tap water (about 2 g of ascorbic acid per 10 l water was added to the drinking water twice a week); ad libitum
- Acclimation period: At least 7 days before the beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- olive oil
- Concentration / amount:
- intradermal induction: 5% in olive oil
percutaneous induction: 50% in olive oil
challenge: 25% in olive oil
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- intradermal induction: 5% in olive oil
percutaneous induction: 50% in olive oil
challenge: 25% in olive oil
- No. of animals per dose:
- Test group: 10, control group: 5
- Details on study design:
- Pretest
For detecting a possible influence on irritating effects of previous intradermal treatment with Freund's adjuvant, animals pretreated with Freund's adjuvant / 0.9% aqueous NaCl-solution (1 : 1) each, in the same manner as intradermal induction about 3 weeks prior to the application of the test substance were used. In the preliminary test after two 24-hour percutaneous occlusive applications within 96 hours the minimum irritant concentratian was found to be a 50% test substance preparation in olive oil DAB 9 and the maximum non-irritant concentration a 25% test substance preparation in olive oil DAB 9 (48 hours after the beginning of application).
Applicability: it was possible to inject a 5% test substance preparation in olive oil DAB 9 resp. in Freund's adjuvant / 0.9%. aqueous NaCl-salution (1 :1) with a syringe.
INTRADERMAL induction: 13 intradermal injections in groups of two per animal
Injections for the test group:
A) front row: 2 injections each of 0.1 ml Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCl-solution in a ratio of 1 :1.
B) middle row: 2 injections each of 0.1 ml of the test substance formulation.
C) back row: 2 injections each of 0.1 ml Freund's adjuvant / 0.9% aqueous NaCl-solution (1 :1) with test substance.
Injections for control groups 1 and 2: The animals were given the same injections but without test substance, only with the formulating agent.
Site of application: shoulder.
Readings: about 24 h and 48 h after the beginning of application.
Percutaneous induction was carried out one week after intradermal induction.
Amount applied: 2 x 4 cm filter paper strips were applied to the skin of the shoulder under an occlusive dressing (the bandage consist of rubberized linenpatches 4 x 4 cm from Russka and Fixomull Stretch (adhesive fleece) from Beiersdorf AG). In the case of liquids the filter paper strip was soaked in the test substance formulation; thus, the animals were exposed to about 0.3 g of the test substance formulation. The control groups were treated analogously to the test group but only with the solvent without the test substance.
Duration of exposure: 48 hours. Site of application: shoulder, same area as in the case of the previous intradermal application. Readings: 48 h after the beginning of application.
Assessment of the skin findings: according to Draize, 1959 (analogous to the pretest)
CHALLENGE
Test concentration: maximum non-irritant concentration. Challenge 21 days after intradermal induction.
Amount applied: 2 x 2 cm filter paper strips were applied to the skin of the flank under an occlusive dressing (the bandage consist of rubberized linenpatches 4 x 4 cm from Russka and Fixomull Stretch (adhesive fleece) from Beiersdorf AG). In the case of liquids the test filter paper strip was soaked in the test substance formulation; thus the animals were exposed to about 0.15 g of the test substance formulation.
Challenge: treatment of the test group and of control group 1 with the test substance formulation. Additionally olive oil DAB 9 was applied as a vehicle. Control group 2 only received olive oil DAB 9.
Duration of exposure: 24 hours. Site of application: intact clipped flank. Readings: 24 and 48 h after the removal of the patch. Assessment of skin findings: according to Draize, 1959 (analogous to the pretest) - Positive control substance(s):
- yes
- Remarks:
- 1-chlor-2,4-dinitro-benzol
Results and discussion
- Positive control results:
- Reading 24 hours after the challenge with 1% of the positive control substance in ethanol in postive skin reaction was observed in 10/10 tested animals.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0 (olive oil only)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0 (olive oil only). No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25% in olive oil
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25% in olive oil. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0 (olive oil only)
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0 (olive oil only). No with. + reactions: 0.0. Total no. in groups: 9.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25% in olive oil
- No. with + reactions:
- 6
- Total no. in group:
- 9
- Clinical observations:
- 6 out of 9 test animals showed very slight erythema.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25% in olive oil. No with. + reactions: 6.0. Total no. in groups: 9.0. Clinical observations: 6 out of 9 test animals showed very slight erythema..
Any other information on results incl. tables
One animal of the test group died after percutaneous induction.
Observation after intradermal induction:
Well-defined erythema and slight edema were observed at the injection sites of the control and test animals, at which only Freund's adjuvant/0.9% aqueous NaCl-solution (1:1) was applied.
Injection of the test substance in olive oil DAB 9 resp. in Freund's adjuvant/0.9%/ aqueous NaCl-solution (1 :1) caused well-defined erythema and slight edema in the test animals. The control animals injected with olive oil DAB 9 (vehicle) showed well-defined erythema.
Observation after percutaneous induction:
Incrustation partially open (caused by the intradermal induction) in addition to well-defined erythema and slight edema were observed in the test and control animals.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.